Historical News Related to Your Article
Bluesky Digital Assets Corp. to Present at the Blockchain & Digital Asset Virtual Investor Conference April 25th
Glass House Brands to Present at OTCQX Best 50 Virtual Investor Conference April 18thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US16 Apr 2024
Bluesky Digital Assets Corp. to Present at the Blockchain & Digital Asset Virtual Investor Conference April 25thBluesky invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comGlobeNewswire - US16 Apr 2024
OTCQX Best 50 Virtual Investor Conference Agenda Announced for April 18thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comGlobeNewswire - US15 Apr 2024
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceDENVER, April 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18 at 9:30 a. [...]GlobeNewswire - US11 Apr 2024
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US09 Apr 2024
OneSoft Solutions To Present at the AI & Technology Hybrid Investor Conference April 11, 2024EDMONTON, Alberta, April 09, 2024 (GLOBE NEWSWIRE) -- OneSoft Solutions Inc. (the “Company” or “OneSoft”) (TSX-V: OSS, OTCQB: OSSIF), a North American developer of cloud-based business solutions, announces that President and COO Brandon Taylor will present at the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research and hosted by VirtualInvestorConferences. [...]GlobeNewswire - US09 Apr 2024
Denny’s Corporation Announces Timing of First Quarter 2024 Results and Conference Call on April 30, 2024SPARTANBURG, S.C., April 09, 2024 (GLOBE NEWSWIRE) -- Denny’s Corporation (the Company) (NASDAQ: DENN), owner and operator of Denny's Inc. (Denny's) and Keke's Inc. (Keke's), will announce financial and operating results for its first quarter ended March 27, 2024, on Tuesday, April 30, 2024, after the markets close. [...]GlobeNewswire - US09 Apr 2024
Nowigence Inc. to Present at the AI & Technology Hybrid Investor Conference April 11thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US08 Apr 2024
GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceLA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstract has been accepted for poster presentation at the 2024 ATS International Conference being held May 17-22, 2024 in San Diego, CA. [...]GlobeNewswire - US08 Apr 2024
Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2024 Earnings Release and Conference CallNEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2024 financial results on Tuesday, April 30, 2024 at 10:00 a.m. Eastern Time. The Company’s first quarter 2024 financial results will be released after the market closes on Monday, April 29, 2024. [...]GlobeNewswire - US08 Apr 2024
InMode Ltd. investors: Please contact the Portnoy Law Firm to recover your losses; April 15, 2024 deadlineInvestors can contact the law firm at no cost to learn more about recovering their lossesGlobeNewswire - US05 Apr 2024
Midland States Bancorp, Inc. To Announce First Quarter 2024 Financial Results on Thursday, April 25EFFINGHAM, Ill., April 05, 2024 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its first quarter 2024 financial results after market close on Thursday, April 25, 2024. Along with the press release announcing the financial results, the Company will publish an investor presentation that will be available on the Webcasts and Presentations page of its investor relations website. [...]GlobeNewswire - US05 Apr 2024
GlobalFoundries Announces Conference Call to Review First Quarter 2024 Financial ResultsMALTA, N.Y., April 05, 2024 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Tuesday, May 7, 2024, at 8:30 a.m. ET following the release of the company’s first quarter 2024 financial results.GlobeNewswire - US05 Apr 2024
COMSTOCK RESOURCES, INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS DATE AND CONFERENCE CALL INFORMATIONFRISCO, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release first quarter 2024 results on May 1, 2024 after the market closes and host its quarterly conference call at 10:00 a.m. CT on May 2, 2024 to discuss the first quarter results.GlobeNewswire - US05 Apr 2024
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor EventsBASKING RIDGE, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. M [. [...]GlobeNewswire - US03 Apr 2024
Reliance Global Group Schedules Fourth Quarter 2023 Financial Results and Business Update Conference CallLakewood, NJ, April 03, 2024 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ: RELI; RELIW) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, April 4, 2024, at 1:00 PM Eastern Time to discuss financial results for the fourth quarter of 2023 and provide a business update. [...]GlobeNewswire - US03 Apr 2024
SOVA to Present at the AI & Technology Hybrid Investor Conference presented by Water Tower Research on April 10Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US02 Apr 2024
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that New York Community Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Case - NYCBSAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of New York Community Bancorp, Inc. (NYSE: NYCB) securities between March 1, 2023 and February 5, 2024, both dates inclusive (the “Class Period”), have until this Monday, April 8, 2024 to seek appointment as lead plaintiff of the New York Community Bancorp class action lawsuit. [...]GlobeNewswire - US02 Apr 2024
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceBOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced that Doug Treco, Ph. [...]GlobeNewswire - US02 Apr 2024
Cerevance to Participate at the 23rd Annual Needham Virtual Health Care ConferenceBOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced participation at the upcoming 23rd Annual Needham Virtual Health Care Conference. The event takes place from April 8-11, 2024. Company management will also host one-on-one meetings during the conference. [...]GlobeNewswire - US02 Apr 2024
Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024Telomir’s pre-clinical studies demonstrate its lead development product, Telomir-1, elongates telomere caps on human normal embryonic fibroblast cells by stimulating the enzyme telomeraseGlobeNewswire - US02 Apr 2024
KULR Technology Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Friday, April 12, 2024 at 4:30 p.m. ETSAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the Company or KULR), a global leader in sustainable energy management, will hold a conference call on Friday, April 12th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2023. [...]GlobeNewswire - US01 Apr 2024
XPOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Xponential Fitness, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Xponential Fitness, Inc. (“Xponential” or “the Company”) (NYSE: XPOF) and certain of its officers. [...]GlobeNewswire - US31 Mar 2024
AMLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx” or “the Company”) (NASDAQ: AMLX) and certain of its officers. [...]GlobeNewswire - US31 Mar 2024
LTRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lantronix, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or “the Company”) (NASDAQ: LTRX) and certain of its officers.GlobeNewswire - US31 Mar 2024
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or “the Company”) (NASDAQ: SAVA) and certain of its officers. [...]GlobeNewswire - US31 Mar 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Anavex, and Innoviz and Encourages Investors to Contact the FirmNEW YORK, March 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Hut 8 Corp. (NASDAQ: HUT), Anavex Life Sciences Corp. (NASDAQ: AVXL), and Innoviz Technologies Ltd. [...]GlobeNewswire - US31 Mar 2024
NOVA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sunnova Energy International Inc. Investors with Substantial Losses Have Opportunity to Lead CaseSAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sunnova Energy International Inc. (NYSE: NOVA) securities between February 25, 2020 and December 7, 2023, inclusive (the “Class Period”), have until April 16, 2024 to seek appointment as lead plaintiff of the Sunnova class action lawsuit. [...]GlobeNewswire - US30 Mar 2024
BLUE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the bluebird bio class action lawsuit seeks to represent purchasers or acquirers of bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 and December 8, 2023, both dates inclusive (the “Class Period”). [...]GlobeNewswire - US30 Mar 2024
NYCB FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages New York Community Bancorp, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action – NYCBNEW YORK, March 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of New York Community Bancorp, Inc. (NYSE: NYCB) between March 1, 2023 and February 5, 2024, both dates inclusive (the “Class Period”), of the important April 8, 2024 lead plaintiff deadline. [...]GlobeNewswire - US30 Mar 2024
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Equinix, Inc. Investors to Inquire About Securities Class Action Investigation – EQIXNEW YORK, March 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Equinix, Inc. (NASDAQ: EQIX) resulting from allegations that Equinix may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US30 Mar 2024
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Next Bridge Hydrocarbons, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionGlobeNewswire - US30 Mar 2024
BOEING DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Boeing Company Investors with Losses in Excess of $1 Million to Secure Counsel Before Important April 1 Deadline in Securities Class Action – BANEW YORK, March 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Boeing Company (NYSE: BA) between October 23, 2019 and January 24, 2024, both dates inclusive (the “Class Period”), of the important April 1, 2024 lead plaintiff deadline. [...]GlobeNewswire - US30 Mar 2024
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against bluebird bio, Inc. (BLUE)Robbins LLP is Investigating the Allegations that Bluebird Bio, Inc. (BLUE) Overstated the Clinical and/or Commercial Prospects of its DrugGlobeNewswire - US30 Mar 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nextdoor, Snowflake, Chemours, and Evolv and Encourages Investors to Contact the FirmNEW YORK, March 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND), Snowflake Inc. [...]GlobeNewswire - US30 Mar 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Innodata, Fox Factory, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the FirmNEW YORK, March 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Innodata Inc. (NASDAQ: INOD), Fox Factory Holding Corp. (NASDAQ: FOXF), Lantronix, Inc. (NASDAQ: LTRX), and Palo Alto Networks, Inc. [...]GlobeNewswire - US30 Mar 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, Amylyx, Xponential, and InMode and Encourages Investors to Contact the FirmNEW YORK, March 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of New York Community Bancorp, Inc. (NYSE: NYCB), Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Xponential Fitness, Inc. [...]GlobeNewswire - US30 Mar 2024
FitLife Brands Announces Fourth Quarter and Full-Year 2023 Results and Investor Conference CallOMAHA, NE, March 29, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” the “Company,” or “We”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the year ended December 31, 2023. The Company’s improved financial performance during the quarter and for the full year was driven primarily by the acquisition of Mimi’s Rock Corp. [...]GlobeNewswire - US29 Mar 2024
C-Bond Systems to File its Form 10-K on April 1, 2024, and Hold Conference Call to Discuss its Financial Results on April 3, 2024The Company will issue a press release on April 2, 2024, with its financial results for 2023 The Company will issue a press release on April 2, 2024, with its financial results for 2023GlobeNewswire - US29 Mar 2024
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024FORT LAUDERDALE, Fla., March 29, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), will report financial results for the fourth quarter and fiscal year ended January 1, 2024 on Monday, April 1, 2024 after the market closes. [...]GlobeNewswire - US29 Mar 2024
Gentex Schedules First Quarter 2024 Earnings Release Date and Conference CallGentex schedules Q1 2024 earnings release and conference call for April 26.GlobeNewswire - US29 Mar 2024
Tri Pointe Homes, Inc. Announces First Quarter 2024 Earnings Release and Conference Call DateINCLINE VILLAGE, Nev., March 29, 2024 (GLOBE NEWSWIRE) -- Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The Company will host a conference call on the same day to discuss the results at 7:00 AM Pacific (10:00 AM Eastern). [...]GlobeNewswire - US29 Mar 2024
SPAR Group, Inc. Announces Timing of Fourth Quarter and Fiscal Year 2023 Results Conference CallAUBURN HILLS, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), a leading global provider of merchandising and marketing services, today announces that it will release its fiscal fourth quarter and full year 2023 results on Monday, April 1, 2024, before the market opens. [...]GlobeNewswire - US28 Mar 2024
Dyadic to Attend Industry Events in AprilJUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry events during the month of April 2024. [...]GlobeNewswire - US27 Mar 2024
Wave Life Sciences to Present at Upcoming Investor ConferencesCAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences in April. [...]GlobeNewswire - US27 Mar 2024
CorMedix Inc. to Present at the Needham Annual Healthcare ConferenceBERKELEY HEIGHTS, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that management will be participating in a fireside chat and investor meetings at the Needham 23rd Annual Healthcare Conference, being held virtually on April 8 – 11, 2024. [...]GlobeNewswire - US27 Mar 2024
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024Inozyme announced that it will host a conference call and webcast on Monday, Apr. 8, 2024 at 8:00 a.m. ET.GlobeNewswire - US26 Mar 2024
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceSANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that the company will be participating in the 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from Monday, April 8 to Thursday, April 11, 2024. [...]GlobeNewswire - US26 Mar 2024
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2023 Financial Results on April 1, 2024FREDERICK, Md., March 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2023, after the close of the financial markets on Monday, April 1, 2024, and will hold a conference call at 4:30 p. [...]GlobeNewswire - US26 Mar 2024
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCNEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (INBS or the Company) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that President and CEO, Harry Simeonidis, and CFO, Spiro Sakiris, are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024 in New York City. [...]GlobeNewswire - US26 Mar 2024
LM Funding America, Inc. Schedules Fourth Quarter 2023 Financial Results and Business Update Conference CallTAMPA, FL, March 25, 2024 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (LM Funding or the Company), a cryptocurrency mining and technology-based specialty finance company, today announced that it will host a conference call on Monday, April 1, 2024, at 11:00 a.m. Eastern Time to discuss financial results for the quarter ended December 31, 2023, and provide a business update. [...]GlobeNewswire - US25 Mar 2024
Safe Harbor Financial to Report Full Year 2023 Financial Results on Monday, April 1, 2024Company to host conference call after the market closes at 4:30 p.m. ET on April 1st Company to host conference call after the market closes at 4:30 p.m. ET on April 1stGlobeNewswire - US25 Mar 2024
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that it will host a virtual key opinion leader (“KOL”) event highlighting expert perspectives on spinal bulbar muscular atrophy (“SBMA”), also known as Kennedy's Disease, on Thursday, April 4, 2024 at 11:00am ET. [...]GlobeNewswire - US25 Mar 2024
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingHANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that the Company will have two posters at the American Association for Cancer Research Annual Meeting 2024 in San Diego from April 5-10, 2024. [...]GlobeNewswire - US25 Mar 2024
Oil & Gas Virtual Investor Conference Agenda: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comGlobeNewswire - US22 Mar 2024
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference CallWEST DES MOINES, Iowa, March 22, 2024 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of West Bank, will report its results for the first quarter of 2024 on Thursday, April 25, 2024 before the markets open.GlobeNewswire - US22 Mar 2024
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces an investor call to be held on Monday, March 25, 2024, at 4:00 p.m. ET.GlobeNewswire - US22 Mar 2024
American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference CallAmerican Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference CallGlobeNewswire - US22 Mar 2024
Kura Sushi USA to Announce Fiscal Second Quarter 2024 Financial Results on April 4, 2024IRVINE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal second quarter 2024 financial results on Thursday, April 4, 2024 at 5:00 p. [...]GlobeNewswire - US21 Mar 2024
LED Lighting and EV Charging Solutions Provider Orion to Webcast LD Micro Investor Conference Presentation Tuesday, April 9th at 9:00am ETLED Lighting and EV Charging Solutions Provider Orion to Webcast LD Micro Investor Conference Presentation on Tuesday, April 9th at 9:00 a.m. ET.GlobeNewswire - US21 Mar 2024
Capricor Therapeutics to Present at Upcoming Investor ConferencesSAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, today announced that the Company is scheduled to present at two upcoming investor conferences. [...]GlobeNewswire - US21 Mar 2024
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024Live webcast presentation on Wednesday, March 20th at 11:50 AM ETGlobeNewswire - US20 Mar 2024
Oil & Gas Virtual Investor Conference Agenda Announced for March 21, 2024Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comGlobeNewswire - US19 Mar 2024
Reed’s Schedules Fourth Quarter and Full Year 2023 Conference Call for March 28 at 5:00 p.m. ETNORWALK, Conn., March 19, 2024 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Thursday, March 28, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the three and twelve months ended December 31, 2023. [...]GlobeNewswire - US19 Mar 2024
AMMO, Inc. to Participate in the 36th Annual ROTH ConferenceSCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announces that it will participate in the 36th Annual Roth Conference being held on March 17-19, 2024 at The Ritz Carlton, Laguna Niguel in Dana Point, CA. [...]GlobeNewswire - US18 Mar 2024
EZCORP Announces Annual Meeting of Shareholders via Conference Call on Thursday, March 21, 2024AUSTIN, Texas, March 18, 2024 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) will hold its Annual Meeting of Stockholders on Thursday, March 21, 2023 at 9:00 a.m. Central time via conference call. Management will discuss the business followed by a question-and-answer session.GlobeNewswire - US18 Mar 2024
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update CallProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update CallGlobeNewswire - US16 Mar 2024
Banking Virtual Investor Conference Agenda: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comGlobeNewswire - US15 Mar 2024
FTC Solar to Present at Roth Conference March 18, 2024AUSTIN, Texas, March 15, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, today announced that it is scheduled to present at the 36th Annual Roth Conference on March 18, 2024 at 9:00 a.m. Pacific Time. A live webcast and replay of this event will be accessible from the Events section of FTC Solar’s website at www. [...]GlobeNewswire - US15 Mar 2024
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2023 and Declaration of Distributions on Common Stock for the Months Ending April 30, May 31, and June 30, 2024.GREENWICH, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended December 31, 2023.GlobeNewswire - US15 Mar 2024
Nuvectis Pharma to Present at the 36th Annual Roth ConferenceFORT LEE, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the 36th Annual Roth Conference. [...]GlobeNewswire - US15 Mar 2024
Stacy M. Brantley and Phillip Branch to Present at the Banking Virtual Investor Conference March 14thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US14 Mar 2024
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsSTAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. Across one platform presentation, an industry symposium and six poster presentations, including one selected as a “Rapid Fire Poster Session,” an invitation-only presentation of the top 20 ACMG posters, GeneDx continues to demonstrate its industry leadership in shaping the future landscape of genomics. [...]GlobeNewswire - US14 Mar 2024
Ledyard National Bank to Present at the Banking Virtual Investor Conference March 14thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US13 Mar 2024
Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceSCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. [...]GlobeNewswire - US13 Mar 2024
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor ForumSAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. [...]GlobeNewswire - US13 Mar 2024
Cerevance Announces Presentation at Alzheimer’s Research UK ConferenceBOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced plans to present a poster at the upcoming Alzheimer’s Research UK Conference, taking place in Liverpool, United Kingdom, March 20-21, 2024. [...]GlobeNewswire - US13 Mar 2024
LiveOne (NASDAQ: LVO) CEO Robert Ellin to Present at the 36th Annual ROTH Conference March 17-19, 2024LOS ANGELES, CA, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – LiveOne (NASDAQ: LVO) announced today that LiveOne’s Founder and CEO, Robert Ellin, will present at the 36th Annual ROTH Conference on Tuesday March 19, between 9:30am and 9:55am PST at the Ritz Carlton, Laguna Niguel, located in Dana Point, CA. [...]GlobeNewswire - US13 Mar 2024
Mama’s Creations to Participate in Upcoming Investor ConferencesEAST RUTHERFORD, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced that management was invited and will attend the 36th Annual ROTH Conference, the LD Micro Invitational, the Planet MicroCap Showcase, the BMO Global Farm to Market Conference and the Craig Hallum Midwest Institutional Investor Conference in Spring 2024. [...]GlobeNewswire - US12 Mar 2024
Expion360 to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on Thursday, March 28, 2024 at 4:30 p.m. Eastern TimeExpion360 to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on Thursday, March 28, 2024 at 4:30 p.m. Eastern TimeGlobeNewswire - US12 Mar 2024
Fortress Biotech to Participate in 36th Annual ROTH ConferenceMIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M. [...]GlobeNewswire - US12 Mar 2024
Quisitive To Launch MazikCare Copilot at the Annual HIMSS Conference: Revolutionizing Healthcare Collaboration with AITORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Quisitive Technology Solutions, Inc. (“Quisitive” or the “Company”) (TSXV: QUIS, OTCQX: QUISF), a trusted Microsoft solutions provider and three-time Microsoft Healthcare Partner of the Year award winner, is proud to announce the upcoming launch of MazikCare copilot, a ground-breaking AI-powered healthcare solution set to redefine collaboration and productivity in the healthcare industry. [...]GlobeNewswire - US12 Mar 2024
Tenax Therapeutics to Present at the 36th Annual Roth ConferenceCHAPEL HILL, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that it will participate in the 36th Annual Roth Conference in Dana Point, California, from March 17-19, 2024. [...]GlobeNewswire - US12 Mar 2024
Safe Harbor Financial to Present at the Banking Virtual Investor Conference March 14thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US11 Mar 2024
First Resource Bancorp, Inc. to Present at the Banking Virtual Investor Conference March 14thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US11 Mar 2024
Bitcoin Depot Schedules Fourth Quarter 2023 Conference Call for Monday, March 25th at 11:00 am ETATLANTA, March 11, 2024 (GLOBE NEWSWIRE) -- Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, will hold a conference call and live audio webcast on Monday, March 25th at 11:00 a.m. Eastern time (8:00 a.m. Pacific Time) to discuss its financial results for the fourth quarter ended December 31, 2023. [...]GlobeNewswire - US11 Mar 2024
Interdigital to Speak at the 36th Annual Roth ConferenceWILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be participating in a fireside chat at the 36th Annual Roth Conference on Monday, March 18th, 2024, at 6:00 PM ET. [...]GlobeNewswire - US11 Mar 2024
Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual MeetingAlumis today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001 at AAD 2024.GlobeNewswire - US09 Mar 2024
Children’s Place, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 29, 2024 deadline.Investors can contact the law firm at no cost to learn more about recovering their lossesGlobeNewswire - US08 Mar 2024
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages The Chemours Company Investors to Inquire About Securities Class Action Investigation – CCNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Chemours Company (NYSE: CC) resulting from allegations that Chemours may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US08 Mar 2024
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sunnova Energy International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NOVANEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sunnova Energy International Inc. (NYSE: NOVA) between February 25, 2020 and December 7, 2023, both dates inclusive (the “Class Period”), of the important April 16, 2024 lead plaintiff deadline. [...]GlobeNewswire - US08 Mar 2024
AMPLITUDE INVESTOR ALERT: Kirby McInerney LLP Reminds Amplitude, Inc. (AMPL) Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the April 15, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL) securities during the period of September 21, 2021 to February 16, 2022 inclusive (“the Class Period”). [...]GlobeNewswire - US08 Mar 2024
Kirby McInerney LLP Reminds Xponential Fitness, Inc. (XPOF) Investors of Class Action Filing and Encourages Investors to Contact the FirmNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the April 9, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF) securities during the period of July 26, 2021 to December 7, 2023 inclusive (“the Class Period”). [...]GlobeNewswire - US08 Mar 2024
MOBILEYE INVESTOR ALERT: Kirby McInerney LLP Alerts Mobileye Global Inc. (MBLY) Investors of Looming Lead Plaintiff Deadline in Class Action LawsuitNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the March 18, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY) securities during the period from January 26, 2023 through January 3, 2024, inclusive. [...]GlobeNewswire - US08 Mar 2024
Arbutus to Participate in Two Upcoming Investor ConferencesWARMINSTER, Pa., March 08, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that the A [. [...]GlobeNewswire - US08 Mar 2024
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International ConferenceAthira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s & Parkinson’s Diseases at AD/PD™ 2024GlobeNewswire - US08 Mar 2024
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease StudiesPITTSBURGH, March 06, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”), is presenting results of proteomic and correlation analyses of two completed clinical studies at the AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference (March 5-9, 2024 in Lisbon, Portugal). [...]GlobeNewswire - US06 Mar 2024
Ollie’s Bargain Outlet Holdings, Inc. Announces Fourth Quarter and Full-Year Fiscal 2023 Release Date and Conference Call InformationHARRISBURG, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the fourth quarter and full-year fiscal 2023 on Wednesday, March 20, 2024, before the market opens. Following the release, at 8:30 a. [...]GlobeNewswire - US06 Mar 2024
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific ConferencesBOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that the company will present preclinical data on its conditionally active immuno-oncology programs at upcoming scientific conferences. [...]GlobeNewswire - US06 Mar 2024
Kelly to Participate in the Sidoti Virtual Investor ConferenceTROY, Mich., March 06, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced it will participate in the Sidoti Virtual Investor Conference on Wednesday, March 13, 2024.GlobeNewswire - US06 Mar 2024
The Shyft Group Announces March 2024 Analyst & Investor EventsNOVI, Mich., March 04, 2024 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (the “Company”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service specialty vehicle markets, announced that management will be hosting analysts and investors at upcoming sell-side conferences and an industry tradeshow in March. [...]GlobeNewswire - US04 Mar 2024
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the FirmNEW YORK, March 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. (NASDAQ: IRTC), Hut 8 Corp. (NASDAQ: HUT), Xponential Fitness, Inc. [...]GlobeNewswire - US03 Mar 2024
DADA IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Dada Nexus Limited Investors to Secure Counsel Before Important March 11 Deadline in Securities Class Action First Filed by the Firm – DADANEW YORK, March 02, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Dada Nexus Limited (NASDAQ: DADA) between May 11, 2023 and January 8, 2024, both dates inclusive (the “Class Period”), of the important March 11, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. [...]GlobeNewswire - US02 Mar 2024
Important March 12, 2024 Deadline Reminder for BioNTech SE Investors: Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE (BNTX) Investors of Securities Fraud Class Action LawsuitRADNOR, Pa., March 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against BioNTech SE (“BioNTech”) (NASDAQ: BNTX). [...]GlobeNewswire - US02 Mar 2024
ROSEN, NATIONAL TRIAL COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTCNEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important April 8, 2024 lead plaintiff deadline. [...]GlobeNewswire - US02 Mar 2024
iTeos to Participate in Upcoming Investor ConferencesWATERTOWN, Mass. and GOSSELIES, Belgium, March 01, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that company mana [. [...]GlobeNewswire - US01 Mar 2024
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March.GlobeNewswire - US01 Mar 2024
Bread Financial™ to Participate in the 2024 RBC Capital Markets Financial Institutions Conference and the Wolfe FinTech Forum 2024Bread Financial Holdings, Inc. today announced the company’s participation in two investor conferences.GlobeNewswire - US28 Feb 2024
XOMA to Present at Upcoming Investor Conferences in MarchEMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following March 2024 investor conferences:GlobeNewswire - US28 Feb 2024
Zevra Therapeutics to Participate at Upcoming Investor ConferencesCELEBRATION, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, President and Chief Executive Officer of Zevra, will present at upcoming investor conferences in March 2024. [...]GlobeNewswire - US28 Feb 2024
Celcuity to Participate in Cowen’s 44th Annual Health Care ConferenceMINNEAPOLIS, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in Cowen’s 44th Annual Health Care Conference to be held in Boston on March 4-6, 2024.GlobeNewswire - US28 Feb 2024
Tourmaline Bio to Present at Upcoming Investor ConferencesNEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced that Sandeep Kulkarni, CEO, will participate in the following investor conferences in March. [...]GlobeNewswire - US27 Feb 2024
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare ConferenceWEST CHESTER, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that they will participate in a fireside chat at the TD Cowen 44th Annual Healthcare Conference, which will be held in Boston, Massachusetts. [...]GlobeNewswire - US27 Feb 2024
Vanqua Bio to Present Pre-Clinical Data on VQ-101, a Novel GCase Activator For The Treatment of GBA-Parkinson’s DiseasePosters to be presented at the AD/PD™ 2024 ConferenceGlobeNewswire - US27 Feb 2024
Cognition Therapeutics to Present at the TD Cowen Health Care ConferencePURCHASE, N.Y., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, announced today that the Company’s president and CEO, Lisa Ricciardi will present at the TD Cowen 44th Annual Health Care Conference taking place March 4-6, 2024. [...]GlobeNewswire - US26 Feb 2024
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceNEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the 44th Annual TD Cowen Health Care Conference, March 4-6, 2024. [...]GlobeNewswire - US26 Feb 2024
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024– Atopic dermatitis and prurigo nodularis skin lesions show evidence of MRGPRX2 mast cell activation and activated macrophages –GlobeNewswire - US26 Feb 2024
Apellis Pharmaceuticals to Present at Upcoming Investor ConferencesWALTHAM, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following March investor conferences:GlobeNewswire - US26 Feb 2024
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNEW YORK, Feb. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or “the Company”) (NASDAQ: SAVA) and certain of its officers. [...]GlobeNewswire - US25 Feb 2024
Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria- Primary and secondary endpoints met with clinically meaningful and statistically significant decreases in urticaria disease activity across multiple dose groups -- Sustained activity with rapid onset within 2 weeks -- Similar improvement in omalizumab-experienced/refractory and omalizumab-naïve di [. [...]GlobeNewswire - US24 Feb 2024
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) TreatmentRESEARCH TRIANGLE PARK, N.C., Feb. 23, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO® (berotralstat) that showed patients who initiated ORLADEYO experienced rapid, substantial and sustained reductions in attack rates through 18 months of treatment regardless of the severity of their disease, their history of prior prophylaxis or their C1-inhibitor (C1-INH) level and function. [...]GlobeNewswire - US23 Feb 2024
Carnegie Clean Energy to Present at Clean/Renewable Energy Virtual Investor Conference February 22ndCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US22 Feb 2024
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsCAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, February 28, 2024, at 8:00 a.m. ET to discuss results for the fourth quarter and full year 2023 and to provide a corporate update. [...]GlobeNewswire - US21 Feb 2024
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2023 financial results will be released before the market opens on Monday, April 1, 2024.GlobeNewswire - US20 Feb 2024
Fortrea to Present at the Barclays 26th Annual Global Healthcare ConferenceDURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 11:15 am ET. [...]GlobeNewswire - US20 Feb 2024
Taboola to Present in Upcoming Investor ConferencesNEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced that members of its management team will present and host one-on-one investor meetings at the following investor conferences:GlobeNewswire - US15 Feb 2024
Perella Weinberg to Present at the Bank of America 2024 Financial Services ConferenceNEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today announced that Andrew Bednar, Partner and Chief Executive Officer, will present at the Bank of America 2024 Financial Services Conference on Wednesday, February 21, 2024 at 4:10PM ET. [...]GlobeNewswire - US14 Feb 2024
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical MeetingNew Data to be Presented on the Bioequivalence Study for OLC New Data to be Presented on the Bioequivalence Study for OLCGlobeNewswire - US14 Feb 2024
Bread Financial™ to Participate in the Bank of America 2024 Financial Services Conference and KBW’s 2024 Fintech & Payments ConferenceBread Financial today announced the company’s participation in the Bank of America Financial Services Conference and KBW’s Fintech & Payments Conference.GlobeNewswire - US13 Feb 2024
nCino Announces Timing of its Fourth Quarter and Fiscal Year 2024 Financial Results Conference CallnCino Announces Timing of its Fourth Quarter and Fiscal Year 2024 Financial Results Conference CallGlobeNewswire - US13 Feb 2024
Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences ConferenceNEW YORK and SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Kimberly Blackwell, M. [...]GlobeNewswire - US13 Feb 2024
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceCANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th. [...]GlobeNewswire - US12 Feb 2024
Stock Yards Bancorp to Participate in the KBW Winter Financial Services ConferenceLOUISVILLE, Ky., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO, Phil Poindexter, President and T. [...]GlobeNewswire - US07 Feb 2024
Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceCELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference being held virtually on Tuesday, February 13, 2024, at 9:20 a. [...]GlobeNewswire - US06 Feb 2024
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13thTORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th – 14th. [...]GlobeNewswire - US06 Feb 2024
ONL Therapeutics to Present at 2024 BIO CEO & Investor ConferenceANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced today that David Esposito, president and chief executive officer, will present a corporate update at the BIO CEO & Investor Conference on Tuesday, February 27 at 2:30 PM ET. [...]GlobeNewswire - US06 Feb 2024
FTI Consulting to Release Fourth Quarter and Full Year 2023 Results and Host Conference CallWASHINGTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, before the New York market opens on Thursday, February 22, 2024.GlobeNewswire - US05 Feb 2024
ARway.ai The Spatial Computing Platform to Present at Small-Cap Growth Virtual Investor Conference February 7thTORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ARway.ai (“ARway” or the “Company”) (CSE: ARWY), (OTC: ARWYF) (FSE: E65), an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision, is pleased to announce CEO Evan Gappelberg will present live at the Small-Cap Growth Virtual Investor Conference, hosted by VirtualInvestorConferences. [...]GlobeNewswire - US05 Feb 2024
America’s Car-Mart, Inc. Schedules Release of Third Quarter Fiscal Year 2024 Results and Conference CallROGERS, Ark., Feb. 05, 2024 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2024 third quarter financial results on Friday, March 8, 2024, before the market opens and senior management will host a conference call at 11:00 a.m ET to discuss the results. [...]GlobeNewswire - US05 Feb 2024
Universal Stainless to Present at TD Cowen's 45th Annual Aerospace/Defense & Industrials Conference on February 14th- Presentation to be Webcast and Archived -GlobeNewswire - US05 Feb 2024
The Shyft Group Announces Fourth Quarter and Year-End 2023 Financial Results Conference CallNOVI, Mich., Feb. 02, 2024 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for ecommerce-driven parcel delivery, as well as the broader commercial, retail, and service specialty vehicle markets, will announce its fourth quarter and year-end 2023 financial results prior to the market opening on Thursday, February 22, 2024. [...]GlobeNewswire - US02 Feb 2024
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 16, 2024MONTVALE, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review Fourth quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. [...]GlobeNewswire - US02 Feb 2024
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024CAMBRIDGE, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, February 15, 2024, at 8:00 a.m. ET to report its fourth quarter and year end 2023 financial results and other business highlights. [...]GlobeNewswire - US02 Feb 2024
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation —GlobeNewswire - US01 Feb 2024
Dyne Therapeutics to Present at February Investor ConferencesWALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present [. [...]GlobeNewswire - US01 Feb 2024
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferencePHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 10:00 a. [...]GlobeNewswire - US31 Jan 2024
SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceSTAMFORD, Conn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference, taking place in New York, New York on Thursday, February 8, 2024 at 2:00 p. [...]GlobeNewswire - US31 Jan 2024
EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceWATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that George Elston, Executive Vice President and Chief Financial Officer of EyePoint Pharmaceuticals, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 12:30 p. [...]GlobeNewswire - US31 Jan 2024
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT ConferenceNew Preclinical Data on UNI-494 in Acute Kidney Injury New Preclinical Data on UNI-494 in Acute Kidney InjuryGlobeNewswire - US29 Jan 2024
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of AficamtenNew Data Show Treatment with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy Resulted in Favorable Structural Remodeling, Improvements in Cardiac Function and Stabilization of Fibrosis New Data Show Treatment with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy [. [...]GlobeNewswire - US25 Jan 2024
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto RicoBOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the Sequire Investor Summit 2024, which is planned for January 23-25, 2024, at Condado Vanderbilt Hotel in San Juan, Puerto Rico. [...]GlobeNewswire - US17 Jan 2024
NN, Inc. Executive Management to Present at the Sidoti Micro-Cap Virtual Investor ConferenceCHARLOTTE, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer, and Michael Felcher, Senior Vice President and Chief Financial Officer, will present virtually at the Sidoti Micro-Cap Virtual Conference on January 18, 2024, at 1:00 p. [...]GlobeNewswire - US16 Jan 2024
Mondee to Participate in 26th Annual Needham Growth ConferenceAUSTIN, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading artificial intelligence (AI) travel technology company and marketplace with a portfolio of global platforms in the leisure and corporate travel sectors, announced that Executive Vice Chairman Orestes Fintiklis and SVP Jeff Houston will present and host one-on-one meetings at the 26th Annual Needham Growth Conference. [...]GlobeNewswire - US10 Jan 2024
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J. [...]GlobeNewswire - US09 Jan 2024
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceWALTHAM, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that Joshua Brumm, president and chief executive officer, is scheduled to present at the 42nd Annual J. [...]GlobeNewswire - US05 Jan 2024
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PT Presentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PTGlobeNewswire - US05 Jan 2024
VPG to Present at the 26th Annual Needham Growth Conference on January 18, 2024Vishay Precision Group to present at Needham investor conference on January 18, 2024GlobeNewswire - US03 Jan 2024
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare ConferenceLOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J. [...]GlobeNewswire - US03 Jan 2024
Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, announced today that Verge Genomics’ co-founder and CEO, Alice Zhang, will present at the 42nd Annual J. [...]GlobeNewswire - US03 Jan 2024
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceSAN FRANCISCO and WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other inflammatory and immunology (I&I) indications, today announced that Michael Henderson, M. [...]GlobeNewswire - US02 Jan 2024
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024GAITHERSBURG, Md., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an abstract on pemvidutide in subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease1 will be presented at the NASH-TAG Conference, which will be held in Park City, UT on January 4-6, 2024. [...]GlobeNewswire - US02 Jan 2024
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceWALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, at 9:45 a.m. PT.GlobeNewswire - US02 Jan 2024
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceWATERTOWN, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA on Monday, January 8, 2024 at 11:15 a. [...]GlobeNewswire - US02 Jan 2024
Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024WATERTOWN, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024, at 9:00 a. [...]GlobeNewswire - US02 Jan 2024
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 a. [...]GlobeNewswire - US02 Jan 2024
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the 42nd Annual J.P. Morgan Healthcare Conference as follows:GlobeNewswire - US29 Dec 2023
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceDANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the 42nd Annual J. [...]GlobeNewswire - US28 Dec 2023
EyePoint Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceWATERTOWN, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the 42nd Annual J. [...]GlobeNewswire - US20 Dec 2023
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & ExpositionSOUTH SAN FRANCISCO, Calif., Dec. 09, 2023 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced a poster presentation at the 2023 American Society of Hematology (ASH) Annual Meeting and Exposition featuring follow-up data from its Phase 1 clinical trial that evaluates NKX101 in patients with relapsed or refractory acute myeloid leukemia (r/r AML). [...]GlobeNewswire - US10 Dec 2023
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023GlobeNewswire - US10 Dec 2023
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders TodayNEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, is hosting a virtual investor event and conference call today from 8 a.m. – 10 a.m. [...]GlobeNewswire - US07 Dec 2023
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus ErythematosusPHILADELPHIA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that it will host a conference call and live audio webcast on Monday, December 11 at 7:30 AM PT/ 10:30 AM ET to discuss initial clinical data supporting a multi-dosing strategy from its ongoing first-in-human Phase 1 ELiPSE-1 trial of CNTY-101, the Company’s lead allogeneic, iPSC-derived CAR-iNK cell therapy, in relapsed/refractory CD19 positive B-cell lymphomas. [...]GlobeNewswire - US06 Dec 2023
The Joint Corp. to Participate in the 12th Annual Roth Deer Valley ConferenceSCOTTSDALE, Ariz., Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, announced that management is scheduled to attend the 12th Annual Roth Deer Valley Conference on December 14th and 15th. The conference is being held at Montage Deer Valley in Park City, UT. [...]GlobeNewswire - US04 Dec 2023
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceFOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Guo-Liang Yu, Ph.D., Co-Founder and Chief Executive Officer of Apollomics and Sanjeev Redkar, Ph. [...]GlobeNewswire - US29 Nov 2023
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will participate in two upcoming investor conferences in December 2023. [...]GlobeNewswire - US29 Nov 2023
Athira Pharma to Participate in Sidoti December Small Cap Investor ConferenceCompany Presentation to highlight novel therapeutic candidates targeting the HGF neurotrophic system in late-stage clinical development in neurodegenerative diseases, including Alzheimer’s disease Company Presentation to highlight novel therapeutic candidates targeting the HGF neurotrophic system in [. [...]GlobeNewswire - US29 Nov 2023
Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced a poster presentation of clinical results for vebreltinib in the treatment of NSCLC with MET exon 14 skipping mutation with or without concurrent MET amplification at the 2023 IASLC North America Conference on Lung Cancer (NACLC), being held on December 1 through 3, 2023 in Chicago, Illinois. [...]GlobeNewswire - US28 Nov 2023
Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin ProgramsLeading scientific and clinical experts to provide perspectives and rationale for TREM2 and progranulin targets on December 7 and December 13, respectively Leading scientific and clinical experts to provide perspectives and rationale for TREM2 and progranulin targets on December 7 and December 13, r [. [...]GlobeNewswire - US28 Nov 2023
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in DecemberCHATHAM, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Tonix Management will present and host investor meetings at the following December in [. [...]GlobeNewswire - US28 Nov 2023
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET Fireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ETGlobeNewswire - US27 Nov 2023
Ollie’s Bargain Outlet Holdings, Inc. Announces Third Quarter Fiscal 2023 Release Date and Conference Call InformationHARRISBURG, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the third quarter of fiscal year 2023 on Wednesday, December 6, 2023, before the market opens. Following the release, at 8:30 a. [...]GlobeNewswire - US22 Nov 2023
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx ConferenceTHE WOODLANDS, Texas, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the following investor conferences taking place November 29 - December 1, 2023:GlobeNewswire - US22 Nov 2023
Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will host a virtual event on December 7 from 8 a.m. - 10 a. [...]GlobeNewswire - US22 Nov 2023
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important December 7 Deadline in Securities Class Action – AXSMNEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM) and certain of its officers. The Class Action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-03925 (LGS), is proposed to be brought on behalf of a Class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Axsome common stock between May 10, 2021 and April 22, 2022, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws. [...]GlobeNewswire - US18 Nov 2023
ROSEN, A TOP RANKED LAW FIRM, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KVUENEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kenvue Inc. (NYSE: KVUE) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s May 2023 initial public offering (“IPO” or the “Offering”), of the important December 8, 2023 lead plaintiff deadline in the securities class action first filed by the Firm. [...]GlobeNewswire - US18 Nov 2023
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Advance Auto Parts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAPNEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Advance Auto Parts, Inc. (NYSE: AAP) between November 16, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important December 8, 2023 lead plaintiff deadline. [...]GlobeNewswire - US18 Nov 2023
ROSEN, A RANKED AND LEADING FIRM, Encourages Capstone Green Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CGRN, CGRNQNEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capstone Green Energy Corp. (NASDAQ: CGRN) (OTC: CGRNQ) between June 14, 2021 and September 22, 2023, both dates inclusive (the “Class Period”), of the important December 12, 2023 lead plaintiff deadline. [...]GlobeNewswire - US18 Nov 2023
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Farfetch Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTCHNEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Farfetch Limited (NYSE: FTCH) between March 9, 2023 and August 17, 2023, both dates inclusive (the “Class Period”), of the important December 19, 2023 lead plaintiff deadline. [...]GlobeNewswire - US17 Nov 2023
Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023GlobeNewswire - US15 Nov 2023
NN, Inc. Executive Management to Participate in the Sidoti Virtual Micro-Cap Investor ConferenceCHARLOTTE, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer, and Michael Felcher, Senior Vice President and Chief Financial Officer, will present virtually at the Sidoti Micro-Cap Virtual Conference on November 15, 2023, at 2:30 p. [...]GlobeNewswire - US14 Nov 2023
Stock Yards Bancorp to Participate in the Piper Sandler 2023 East Coast Financial Services ConferenceLOUISVILLE, Ky., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO and T. [...]GlobeNewswire - US08 Nov 2023
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare ConferenceALPHARETTA, Ga., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, will participate in a fireside chat at the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023 at 8:35 a. [...]GlobeNewswire - US08 Nov 2023
Atea Pharmaceuticals Announces Participation at Upcoming Investor ConferencesBOSTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that members of the Atea management team will participate in and present a business update at the following investor conferences in November. [...]GlobeNewswire - US08 Nov 2023
Quest Resource Holding Corporation to Present and Host 1x1 Investor Meetings at the 15th Annual Southwest IDEAS Investor Conference on November 15th & 16th in Dallas, TXTHE COLONY, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest”), a national leader in environmental waste and recycling services, today announced Ray Hatch, Chief Executive Officer and Brett Johnston, Chief financial Officer will present at the Southwest IDEAS Investor Conference on Thursday November 16, 2023, at The Statler in Dallas, TX. [...]GlobeNewswire - US02 Nov 2023
Hywin Holdings to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 8th 2023Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventGlobeNewswire - US01 Nov 2023
iPower Schedules Fiscal First Quarter 2024 Conference Call for November 14, 2023 at 4:30 p.m. ETDUARTE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home and garden products, as well as a provider of value-added ecommerce services, will host a conference call on Tuesday, November 14, 2023 at 4:30 p. [...]GlobeNewswire - US01 Nov 2023
Bel Fuse Announces Upcoming Investor Conference Schedule for November 2023WEST ORANGE, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its investor conference schedule for November 2023:GlobeNewswire - US31 Oct 2023
GCM Grosvenor to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 8, 2023CHICAGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the third quarter 2023 on Wednesday, November 8, 2023.GlobeNewswire - US25 Oct 2023
Xos, Inc. Announces Third Quarter 2023 Earnings Release Date and Conference CallLOS ANGELES, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Xos, Inc. (NASDAQ: XOS), a leading electric truck manufacturer and fleet services provider, announced it will release its third quarter 2023 operating results on Thursday, November 9, 2023 after the close of the U.S. financial markets.GlobeNewswire - US24 Oct 2023
Interactive Strength, Inc. d/b/a FORME (Nasdaq: TRNR) to Present at the Webull LIVE! with Corporate Connect: Virtual Consumer Tech WebinarInteractive Strength recently signed agreement to acquire CLMBR, creating a high-growth, B2B focused, connected fitness platformGlobeNewswire - US17 Oct 2023
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery ConferenceWOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today will present research demonstrating Comera’s SQore™ platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass. [...]GlobeNewswire - US16 Oct 2023
Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantages over covalent approaches –GlobeNewswire - US14 Oct 2023
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International ConferenceWILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage precision oncology company, announces multiple clinical and preclinical posters at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, known as the Triple Meeting, from October 11 - 15, 2023 at the Hynes Convesntion Center in Boston, MA. [...]GlobeNewswire - US14 Oct 2023
Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and enhanced clinical efficacy irrespective of PD-L1 status when administered in combination with chemotherapy —GlobeNewswire - US14 Oct 2023
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceBERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that an abstract has been accepted for presentation at the IDWeek 2023 meeting being held in Boston, Massachusetts, October 11 – 15. [...]GlobeNewswire - US11 Oct 2023
Cidara Therapeutics Presents New Preclinical and Clinical Data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced new data on its drug-Fc conjugate (DFC) candidate, CD388, at IDWeek 2023. [...]GlobeNewswire - US11 Oct 2023
Redsense Medical to Present at the Small Cap Growth Virtual Investor Conference October 12thCompany invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US05 Oct 2023
SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023DENVER, Oct. 05, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the 8th Annual Dawson James Small Cap Growth Conference on Thursday, October 12 at 2:30 p. [...]GlobeNewswire - US05 Oct 2023
Maravai LifeSciences Hosts 2023 Investor R&D; DayHighlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlookGlobeNewswire - US29 Sep 2023
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines ConferenceCAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan 7th Annual Genetic Medicines Conference in New York City on Monday, October 2, 2023. [...]GlobeNewswire - US25 Sep 2023
Financial Services Virtual Investor Conference: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comGlobeNewswire - US22 Sep 2023
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023Company to share interim data updates from ongoing Phase 1/2 trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) Company to share interim data updates from ongoing Phase 1/2 trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)GlobeNewswire - US20 Sep 2023
Lever Global Corporation (OTCQB: LVER) to Present at the Financial Services Virtual Investor Conference on September 21, 2023Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US19 Sep 2023
Alliance Entertainment to Present at LD Micro Main Event XVI Conference on October 3, 2023SUNRISE, Fla., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance Entertainment,” “Company”), a distributor and wholesaler of the world’s largest in stock selection of music, movies, video games, electronics, arcades, and collectibles, today announced it will participate at the LD Micro Main Event XVI Conference taking place October 3-4, 2023. [...]GlobeNewswire - US19 Sep 2023
FendX Technologies Inc. to Present at the OTCQB Venture Virtual Investor Conference August 3rd, 2023Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences. [...]GlobeNewswire - US01 Aug 2023
Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rdThe Company invites analysts, individual and institutional investors to participate online at VirtualInvestorConferences.com The Company invites analysts, individual and institutional investors to participate online at VirtualInvestorConferences.comGlobeNewswire - US31 Jul 2023
Battery & Precious Metals Virtual Investor Conference: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comGlobeNewswire - US28 Jul 2023
Workhorse Group to Participate in the 9th Annual ROTH London Conference from June 20-22, 2023CINCINNATI, June 15, 2023 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company with a vision to pioneer the transition to zero emission commercial vehicles, is scheduled to participate at the 9th Annual ROTH London Conference, which is being held from June 20-22, 2023 at the Four Seasons Hotel London at Park Lane in London, UK. [...]GlobeNewswire - US15 Jun 2023
ReShape Lifesciences® to Participate in Investor and Industry Conferences in JuneSAN CLEMENTE, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced participation in the following investor and industry conferences in June:GlobeNewswire - US14 Jun 2023
electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLCROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest. [...]GlobeNewswire - US14 Jun 2023
Daré Bioscience to Present at the Maxim Group Virtual Healthcare ConferenceSAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will present at the Healthcare Virtual Conference presented by Maxim Group LLC and hosted by M-Vest, being held June 20 – 22, 2023. [...]GlobeNewswire - US14 Jun 2023
SELLAS to Participate in Maxim Group Healthcare Virtual ConferenceNEW YORK, June 13, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Angelos Stergiou, MD, ScD h. [...]GlobeNewswire - US13 Jun 2023
Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex BlepharitisWebcast scheduled for Thursday, June 15 at 8:30am PT Webcast scheduled for Thursday, June 15 at 8:30am PTGlobeNewswire - US12 Jun 2023
Lisata Therapeutics to Present at the GCFF Innovation and Healthcare Virtual ConferenceBASKING RIDGE, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announces its participation in the upcoming GCFF Innovation & Healthcare virtual conference on June 15, 2023. [...]GlobeNewswire - US12 Jun 2023
YS INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIHNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. (NASDAQ: YS, SMIH).GlobeNewswire - US10 Jun 2023
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Microvast Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – MVST, MVSTWNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Microvast Holdings, Inc. (NASDAQ: MVST, MVSTW) resulting from allegations that Microvast may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
RLMD INVESTOR NEWS: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Relmada Therapeutics, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – RLMDNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Relmada Therapeutics, Inc. (NASDAQ: RLMD) resulting from allegations that Relmada may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
FUTU LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Futu Holdings Limited Investors to Inquire About Securities Class Action Investigation – FUTUNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
FOUR SHAREHOLDER ALERT: ROSEN, A LEADING LAW FIRM, Encourages Shift4 Payments, Inc. Investors to Inquire About Securities Class Action Investigation – FOURNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Shift4 Payments, Inc. (NYSE: FOUR) resulting from allegations that Shift4 may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
IART INVESTOR NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation – IARTNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART) resulting from allegations that Integra may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
FOX, FOXA INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fox Corporation Investors to Inquire About Class Action Investigation – FOX, FOXANEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Fox Corporation (NASDAQ: FOX, FOXA) resulting from allegations that FOX may have issued materially misleading business information to the investing public. [...]GlobeNewswire - US10 Jun 2023
TLPFY FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Teleperformance SE Investors to Secure Counsel Before Important June 20 Deadline in Securities Class Action – TLPFYNEW YORK, June 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Receipts (“ADRs”) of Teleperformance SE (OTC: TLPFY) between July 29, 2020 and November 9, 2022, both dates inclusive (the “Class Period”), of the important June 20, 2023 lead plaintiff deadline. [...]GlobeNewswire - US10 Jun 2023
DEADLINE ALERT for S and TIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersLOS ANGELES, June 09, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.GlobeNewswire - US10 Jun 2023
June 8th KCSA Cannabis Virtual Investor Conference: Presentations Now Available for Online ViewingCompany Executives Share Vision and Answer Questions at VirtualInvestorConferences.com Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comGlobeNewswire - US09 Jun 2023
SS Innovations International Presents at MoneyShow Virtual Expo“The Progression of Surgical Robotics: Introducing the SSi Mantra System” Video Presentation Now Available for ViewingGlobeNewswire - US09 Jun 2023
Diamond Equity Research to Host Global Select Emerging Growth Invitational Virtual Investor Conference on June 13th, 2023Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Invest [. [...]GlobeNewswire - US09 Jun 2023
Nextleaf to Present at Virtual Investor Conferences on June 8thThe Company invites individual and institutional investors, as well as advisors, analysts, and current shareholders to attend a live presentation and press conference by Nextleaf® Co-Founder and CEO The Company invites individual and institutional investors, as well as advisors, analysts, and curren [. [...]GlobeNewswire - US08 Jun 2023
Silex Systems to Present at the OTCQX Best 50 Virtual Investor Conference on 15 June 2023 (EDT)NEW SOUTH WALES, Australia, June 08, 2023 (GLOBE NEWSWIRE) -- Silex Systems Limited (Silex) (ASX: SLX) (OTCQX: SILXY) is pleased to advise that Dr Michael Goldsworthy, CEO and Managing Director, will present live at the OTCQX Best 50 Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on Thursday, 15 June 2023. [...]GlobeNewswire - US08 Jun 2023
IMUNON’s CEO Presents Business Overview to Investors and Senior Biopharmaceutical Professionals at the BIO 2023 International ConventionDr. Corinne Le Goff highlights clinical progress across the Company’s pipeline, provides context on the promise of DNA as a therapeutic and a vaccineGlobeNewswire - US08 Jun 2023
Ascendis Pharma to Participate in the Goldman Sachs 44th Annual Global Healthcare ConferenceCOPENHAGEN, Denmark, June 07, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13. [...]GlobeNewswire - US07 Jun 2023
SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International ConventionSAB Biotherapeutics President & Chief Executive Officer Eddie Sullivan, Ph.D. to present novel DiversitAb™ platform pipeline, with emphasis on partnering influenza therapeutic, SAB-176 SAB Biotherapeutics President & Chief Executive Officer Eddie Sullivan, Ph.D. to present novel DiversitAb™ platform [. [...]GlobeNewswire - US30 May 2023
Aprea Therapeutics to Present at BIO International ConventionDOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced that Oren Gilad, Ph. [...]GlobeNewswire - US30 May 2023
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International ConventionPamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing link in drug discovery Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity wi [. [...]GlobeNewswire - US23 May 2023
MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International ConferenceNEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced presentation of clinical data from its allo-iNKTs (agenT-797) in COVID-19 associated Acute Respiratory Distress Syndrome (CARDS) at the American Thoracic Society (ATS) International Conference in Washington D. [...]GlobeNewswire - US22 May 2023
SAB Biotherapeutics Presents Virtual 2023 R&D; Day Portfolio Update: Breakthrough Immunotherapy InnovationsSIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human polyclonal antibodies, without the need for human donors, announced today that it will be hosting its Virtual 2023 Annual R&D Day on Wednesday, June 14, 2023, at 1:30 P. [...]GlobeNewswire - US19 May 2023
Ultragenyx to Present at the 2023 Barclays - Gene Editing & Gene Therapy SummitNOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company's chief medical officer, will present at the 2023 Barclays - Gene Editing & Gene Therapy Summit on Wednesday, May 24, 2023, at 8:50 a. [...]GlobeNewswire - US19 May 2023
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeStudy Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic DevicesGlobeNewswire - US19 May 2023
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023NEW YORK, May 15, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday May 16th and Wednesday, May 17th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. [...]GlobeNewswire - US15 May 2023
First Pacific to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 17 May 2023Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventGlobeNewswire - US15 May 2023
Royal KPN N.V. to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 17 May 2023Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventGlobeNewswire - US12 May 2023
FG Group Holdings to Announce 2023 First Quarter Financial Results and Host Conference CallCHARLOTTE, N.C., May 12, 2023 (GLOBE NEWSWIRE) -- FG Group Holdings Inc. (NYSE American: FGH) (the “Company” or “FG Group Holdings”) today announced that the Company will issue its 2023 first quarter financial results after the market close on Monday, May 15, 2023. The Company’s financial results and an accompanying slide presentation will be available on the Investor Relations page of the Company’s website at https://fg. [...]GlobeNewswire - US12 May 2023
Vection Technologies to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 17th May 2023Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventGlobeNewswire - US11 May 2023
Avenue Therapeutics to Present at Aegis Capital Virtual ConferenceMIAMI, April 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Aegis Capital Virtual Conference taking place on Thursday, May 4, 2023, at 4:00 p. [...]GlobeNewswire - US27 Apr 2023
T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 ConferenceLEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted new clinical data supporting the T2Bacteria® Panel and the T2Candida® Panel, that was recently presented at the European Society of Clinical Microbiology and Infectious Diseases (ECCMID) conference in Copenhagen, Denmark. [...]GlobeNewswire - US26 Apr 2023
High Wire to Present Overwatch Cybersecurity Platform at Kaseya Connect Global Conference in Las Vegas, April 24-27, and Host VIP Event on April 26Register Today to Attend High Wire’s VIP Bourbon Tasting Event & Open MXDR Demo at the MGM Grand SKYLOFTS on April 26 Register Today to Attend High Wire’s VIP Bourbon Tasting Event & Open MXDR Demo at the MGM Grand SKYLOFTS on April 26GlobeNewswire - US24 Apr 2023
BioVie To Present Data from NE3107 Phase 2 Open-Label Trial at Society of Biological Psychiatry Annual MeetingCARSON CITY, Nev., April 20, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a data abstract from its Phase 2 open label trial evaluating NE7107 in degenerative dementias has been accepted for presentation at the 78th Annual Scientific Convention of the Society of Biological Psychiatry, to be held in San Diego, CA April 27-29, 2023. [...]GlobeNewswire - US20 Apr 2023
SoundThinking to Present at the Ladenburg Thalmann Technology Expo 2023 on April 27, 2023FREMONT, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership, will be presenting at the Ladenburg Thalmann Tech Expo on April 27, 2023, at the Convene in New York, NY. [...]GlobeNewswire - US20 Apr 2023
Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto RicoBASKING RIDGE, NJ, April 19, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announces its participation in the upcoming Sequire Investor Summit to be held April 24-26, 2023, at La Concha Resort in San Juan, Puerto Rico. [...]GlobeNewswire - US19 Apr 2023
Spero Therapeutics to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious DiseasesCAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced two poster presentations at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held April 15-18, 2023, in Copenhagen, Denmark. [...]GlobeNewswire - US14 Apr 2023
GoLogiq to Host Investor Call April 20, 2023 at 4:30 p.m. ETCompany to Discuss Recent M&A Activity, NYSE American Uplist, 2022 Spin-off Share Distribution, and 2023 Outlook Company to Discuss Recent M&A Activity, NYSE American Uplist, 2022 Spin-off Share Distribution, and 2023 OutlookGlobeNewswire - US13 Apr 2023
MamaMancini’s to Host Fourth Quarter & Fiscal Year 2023 Earnings Call on April 26 at 4:30 p.m. Eastern TimeEAST RUTHERFORD, NJ, April 13, 2023 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a leading national marketer and manufacturer of fresh Deli prepared foods, will release financial results for the fiscal fourth quarter ended January 31, 2023 after market close on April 26, 2023.GlobeNewswire - US13 Apr 2023
Overstock Scheduled to Release First Quarter 2023 Financial Results on April 27SALT LAKE CITY, April 13, 2023 (GLOBE NEWSWIRE) -- Overstock.com, Inc. (NASDAQ:OSTK), a leading online furniture and home furnishings retailer, is scheduled to release first quarter financial results for the period ended March 31, 2023, on Thursday, April 27, 2023, before the market opens. The company has scheduled a conference call and webcast for 8:30am ET that day to discuss these results and take questions from participants during the live event. [...]GlobeNewswire - US13 Apr 2023
SCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in DenmarkJERSEY CITY, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of interim data across a diverse array of infection types from its ongoing Phase 3 FURI and CARES studies, as well as the innovative study design of its ongoing Phase 3 MARIO trial of oral ibrexafungerp treatment after an intravenous (IV) echinocandin, at the 33rd Annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Copenhagen, Denmark, April 15-18, 2023. [...]GlobeNewswire - US13 Apr 2023
Ascendis Pharma Announces First Quarter 2023 Financial Results and Business Update Conference Call on April 27COPENHAGEN, Denmark, April 13, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the company will hold a conference call and live webcast on Thursday, April 27, 2023, at 4:30 p.m. Eastern Time (ET) to review its first quarter 2023 financial results and provide a business update. [...]GlobeNewswire - US13 Apr 2023
Prelude Therapeutics to Present at American Association for Cancer Research 2023 ConferenceEight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline Eight Abstracts Demonstrate Progress of Prelude’s Differentiated PipelineGlobeNewswire - US11 Apr 2023
First Commonwealth to Host First Quarter 2023 Earnings Conference Call on Wednesday, April 26, 2023INDIANA, Pa., April 07, 2023 (GLOBE NEWSWIRE) -- First Commonwealth Financial Corporation (NYSE: FCF) announced today that it will host a conference call on Wednesday, April 26, 2023 at 2:00 p.m. Eastern Time to discuss financial results for the quarter ended March 31, 2023. The call will be hosted by T. [...]GlobeNewswire - US07 Apr 2023
First Western Financial, Inc. to Report First Quarter 2023 Financial Results on Thursday, April 27DENVER, April 07, 2023 (GLOBE NEWSWIRE) -- First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western”), announced today that it will release financial results for its first quarter ended March 31, 2023 after the markets close on Thursday, April 27, 2023. [...]GlobeNewswire - US07 Apr 2023
Hydreight Technologies Inc to Present at the Technology Virtual Investor Conference on April 13, 2023VANCOUVER, British Columbia and LAS VEGAS, April 06, 2023 (GLOBE NEWSWIRE) -- IV Hydreight Technologies Inc. (“Hydreight” or the “Company“) (TSXV:NURS) (FSE: SO6) (OTCQB: HYDTF) is presenting at VirtualInvestorConferences.com on April 13th at 3:00 pm EST (12:00 pm PST)GlobeNewswire - US06 Apr 2023
Duck Creek Technologies VP of Product Strategy and Co-Founder, Andy Yohn, to Present at the 2023 Verisk Insurance ConferenceBoston, April 05, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, is excited to announce that Andy Yohn, VP of Product Strategy and co-founder of Duck Creek, will be presenting with Verisk at the 2023 Verisk Insurance Conference in Scottsdale, AZ from April 11–14, 2023. [...]GlobeNewswire - US05 Apr 2023
Clever Leaves to Present at Sequire Cannabis & Psychedelics Conference on April 5, 2023 at 2:30 p.m. ETTOCANCIPÁ, Colombia, April 03, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that it will be presenting virtually at the upcoming Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, at 2:30 p. [...]GlobeNewswire - US03 Apr 2023
QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023QSAM invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.GlobeNewswire - US20 Mar 2023
ReShape Lifesciences® to Present at the Q2 Virtual Investor SummitSAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at the Q2 Virtual Investor Summit on Wednesday, March 29 at 1:00 pm ET. [...]GlobeNewswire - US15 Mar 2023
HeartCore to Present Virtually at the Sidoti Small-Cap Conference on March 23rd, 2023NEW YORK and TOKYO, March 14, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (“HeartCore” or the “Company”), a leading software development company offering Customer Experience Management Platform (CXM Platform) and Digital Transformation (“DX”), will be presenting and holding one-on-one meetings virtually at the Sidoti & Co. [...]GlobeNewswire - US14 Mar 2023
AMMO, Inc. to Participate in Fireside Chat at the 35th Annual ROTH ConferenceSCOTTSDALE, Ariz., March 13, 2023 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announces today that management will participate in a fireside chat at the 35th Annual Roth Conference being held on March 12-14, 2023 at The Ritz Carlton, Laguna Niguel in Dana Point, California. [...]GlobeNewswire - US13 Mar 2023
Vivos Therapeutics to Participate in Fireside Chat at the 35th Annual ROTH ConferenceLITTLETON, Colo., March 08, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment of breathing related sleep disorders in adults, including mild-to-moderate obstructive sleep apnea (OSA) and snoring, today announced that Kirk Huntsman, Vivos’ Chairman and CEO and Brad Amman, CFO, will participate in a fireside chat at the 35th Annual ROTH Conference on Tuesday, March 14, 2023 at 1:30 pm PT (4:30 pm ET). [...]GlobeNewswire - US08 Mar 2023
Dyne Therapeutics to Present at Upcoming Investor ConferencesWALTHAM, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to partici [. [...]GlobeNewswire - US07 Mar 2023
Zevra Therapeutics to Present at 35th Annual Roth ConferenceCELEBRATION, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare disease therapeutics company, today announced that Richard W. Pascoe, the Company’s Chief Executive Officer, will participate in a fireside chat at the 35th Annual Roth Conference on Monday, March 13, 2023, at 2:00 p. [...]GlobeNewswire - US06 Mar 2023
The Joint Corp. to Participate in the 35th Annual Roth ConferenceSCOTTSDALE, Ariz., March 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to attend the 35th Annual Roth Conference on March 13th and 14th. The conference is being held at The Ritz-Carlton, Laguna Niguel in Dana Point, CA. [...]GlobeNewswire - US06 Mar 2023
M2 Compliance to Sponsor the 35th Annual ROTH ConferenceFort Lauderdale, March 03, 2023 (GLOBE NEWSWIRE) -- M2 Compliance, a leading SEC-registered filing agent and financial printer, will be sponsoring the 35th Annual Roth Conference, which will be held Sunday, March 12 through Tuesday, March 14, 2023 at The Ritz Carlton, Laguna Niguel in Dana Point, California. [...]GlobeNewswire - US04 Mar 2023
The Shyft Group to Present at the Raymond James 44th Annual Institutional Investors ConferenceNOVI, Mich., March 03, 2023 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service specialty vehicle markets, today announced that Daryl Adams, President and Chief Executive Officer, and Jon Douyard, Chief Financial Officer, will present at the Raymond James 44th Annual Institutional Investors Conference on Monday, March 6, 2023. [...]GlobeNewswire - US03 Mar 2023
Asure Software to Attend the 35th Annual Roth ConferenceAUSTIN, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today announced that Chairman and Chief Executive Officer Pat Goepel and President and Chief Revenue Officer Eyal Goldstein will attend the 35th Annual Roth Conference on March 12-14, 2023. [...]GlobeNewswire - US03 Mar 2023
Kura Oncology to Participate in Upcoming Investor ConferencesSAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is [. [...]GlobeNewswire - US01 Mar 2023
Relay Therapeutics to Participate in Two Upcoming Investor ConferencesCAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:05 p. [...]GlobeNewswire - US01 Mar 2023
Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s CancerLEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Agenus (Nasdaq: AGEN), a clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, today announced plans to present updated data on its lead program botensilimab (Fc-enhanced anti-CTLA-4), at the Society of Gynecologic Oncology (SGO) 37th Annual Meeting on Women’s Cancer, to be held March 25-28 in Tampa, FL. [...]GlobeNewswire - US28 Feb 2023
Xilio Therapeutics to Present at Upcoming Investor ConferencesWALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced its participation in the following upcoming investor conferences:GlobeNewswire - US27 Feb 2023
Humacyte to Present at Upcoming Investor Conferences in MarchDURHAM, N.C., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and advanced tissue constructs and organ systems at commercial scale, today announced that Laura Niklason, M.D. [...]GlobeNewswire - US27 Feb 2023
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023PHILADELPHIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, announced updated clinical data from Imagine-1, a Phase 1/2 study of PBGM01, a gene therapy for GM1 gangliosidosis (GM1), are being presented today at the 19th Annual WORLDSymposium™. [...]GlobeNewswire - US24 Feb 2023
Stablix to Present at Wells Fargo 2023 Targeted Protein Degradation SummitNEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Kevin Sprott, Chief Operating Officer, will participate in a panel discussion at the Wells Fargo 2023 Targeted Protein Degradation (TPD) Virtual Summit. [...]GlobeNewswire - US17 Feb 2023
Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership SummitWALTHAM, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive officer, will participate in Citi’s 2023 Virtual Oncology Leadership Summit on Thursday, February 23, 2023, at 9:00 a. [...]GlobeNewswire - US16 Feb 2023
Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023– Updated interim data from first six patients in Phase 1/2 Imagine-1 study of PBGM01 for GM1 Gangliosidosis to be shared in oral platform and poster presentationsGlobeNewswire - US15 Feb 2023
ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye ResearchOral presentation will review the scientific rationale for Fas receptor inhibition, a unique mechanism-of-action, in the treatment of patients with progressing open-angle glaucoma (OAG) Oral presentation will review the scientific rationale for Fas receptor inhibition, a unique mechanism-of-action, [. [...]GlobeNewswire - US13 Feb 2023
Aligos Therapeutics to Present at the SVB Securities Global Biopharma ConferenceSOUTH SAN FRANCISCO, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in NASH and viral diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the virtual SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 5:00 p. [...]GlobeNewswire - US10 Feb 2023
Arbutus to Participate in Three Upcoming Investor ConferencesWARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Arbutus management team [. [...]GlobeNewswire - US06 Feb 2023
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023- Company to share topline data from ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency (PXE) –GlobeNewswire - US06 Feb 2023
Monte Rosa Therapeutics to Present at Upcoming Investor ConferencesBOSTON, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company is scheduled to participate in fireside chats and industry panels, as well as present at the fol [. [...]GlobeNewswire - US03 Feb 2023
BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 American Academy of Allergy, Asthma & Immunology Annual MeetingRESEARCH TRIANGLE PARK, N.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present four abstracts featuring data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2023 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, which is being held in San Antonio, Texas, from February 24-27, 2023. [...]GlobeNewswire - US03 Feb 2023
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology DayWALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive officer, will participate in a fireside chat at the Guggenheim Healthcare Talks Oncology Day on Thursday, February 9, 2023, at 3:55 p. [...]GlobeNewswire - US02 Feb 2023
ONL Therapeutics to Present at 2023 BIO CEO & Investor ConferenceANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced today that David Esposito, chief executive officer, will present a corporate update at the BIO CEO & Investor Conference on Monday, February 6, 2023, at 2:00 p. [...]GlobeNewswire - US02 Feb 2023
Century Therapeutics to Present at Upcoming Investor ConferencesPHILADELPHIA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the management team will participate in the following in [. [...]GlobeNewswire - US01 Feb 2023
First Wave BioPharma to Present at the BIO CEO & Investor ConferenceBOCA RATON, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced James Sapirstein, Chairman, President and CEO, will present at the BIO CEO & Investor Conference being held February 6-9, 2023, at the Marriott Marquis in New York City. [...]GlobeNewswire - US30 Jan 2023
Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers SymposiumCAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenetic mRNA medicines, today announced that it will present a trial-in-progress poster at the upcoming American Society for Clinical Oncology 2023 Gastrointestinal Cancers Symposium (ASCO-GI), taking place in San Francisco, Calif. [...]GlobeNewswire - US17 Jan 2023
Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology Annual Meeting– 30%% CR rate at 600 mg in 20 patients with relapsed/refractory NPM1-mutant AML –– Low frequency of differentiation syndrome, including 5%% rate (1/20) of ≥ Grade 3 among NPM1-mutant patients treated at 600 mg –– 600 mg determined as recommended Phase 2 dose for ziftomenib in NPM1-mutant AML following positive Type C meeting with FDA –– Company expects to dose first patient in Phase 2 registration-directed trial in NPM1-mutant AML in first quarter of 2023 –– Further clinical development of KTM2A-rearranged AML to be pursued in combination with standards of care –– Multiple combination studies of ziftomenib in NPM1-mutant and KMT2A-rearranged AML anticipated in 2023 –– Management to host investor event today at 11:15 a. [...]GlobeNewswire - US10 Dec 2022
Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MNDATH-1105 demonstrated consistent improvements across measures of motor function, nerve function, and neurodegeneration in a TDP-43 mouse model of ALSGlobeNewswire - US05 Dec 2022
Kura Oncology to Host Investor Event on December 10, 2022In-person event and live webcast to follow oral presentation of data from KOMET-001 at ASH in New Orleans In-person event and live webcast to follow oral presentation of data from KOMET-001 at ASH in New OrleansGlobeNewswire - US01 Dec 2022
Cognition Therapeutics Presents Scientific Rationale, Clinical Biomarker and Preclinical Data supporting a Phase 2 Clinical Trial with CT1812 in Geographic Atrophy Secondary to Dry AMDPURCHASE, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced that the scientific rationale, supporting proof-of-concept data and design of the planned Phase 2 trial of CT1812 in geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD) will be communicated in an oral presentation at the 2022 Dry AMD Therapeutic Development Summit. [...]GlobeNewswire - US01 Dec 2022
Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MNDHGF/MET small molecule positive modulator provides neuroprotection and improves motor and nerve function in a TDP-43 mouse model of ALS HGF/MET small molecule positive modulator provides neuroprotection and improves motor and nerve function in a TDP-43 mouse model of ALSGlobeNewswire - US28 Nov 2022
Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12WALTHAM, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that the company will host a live virtual program on Thursday, December 1, 2022, at 12:30 p. [...]GlobeNewswire - US23 Nov 2022
Puyi Inc. to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 16 November 2022Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventGlobeNewswire - US09 Nov 2022
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2022NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Wednesday, November 16 and Thursday, November 17, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. [...]GlobeNewswire - US09 Nov 2022
Repligen Corporation to Present at Upcoming Investor ConferencesWALTHAM, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences.GlobeNewswire - US08 Nov 2022
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business UpdateConference call to be held Thursday, November 10, 2022 at 8:30 AM ET Conference call to be held Thursday, November 10, 2022 at 8:30 AM ETGlobeNewswire - US08 Nov 2022
Relay Therapeutics to Participate in Two Upcoming Investor ConferencesCAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month at the H.C. Wainwright 3rd Annual Precision Oncology Virtual Conference on Monday, November 14, 2022 at 10:00 a.m. ET and the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 1:15 p. [...]GlobeNewswire - US07 Nov 2022
Bionik Laboratories to Present at the Q4 Virtual Investor SummitPresentation to be Webcast at 9:00 AM (ET), Monday, November 14, 2022GlobeNewswire - US07 Nov 2022
Kessler Topaz Meltzer & Check, LLP Reminds Investors of November 21, 2022 Deadline in Securities Fraud Class Action against Fulgent Genetics, Inc. Investors and Urges Investors with Substantial Losses to Contact the FirmRADNOR, Pa., Nov. 05, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT). [...]GlobeNewswire - US05 Nov 2022
NETSOL Technologies Sets First Fiscal Quarter 2023 Conference Call for Thursday, November 10, 2022, at 9:00 a.m. ETCALABASAS, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Thursday, November 10, 2022 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss its financial results for the fiscal first quarter 2023. [...]GlobeNewswire - US04 Nov 2022
Hudson Global to Present at the Sidoti & Company Fall Small-Cap Virtual Investor Conference on September 22OLD GREENWICH, Conn., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) (Hudson), a leading global talent solutions company, announced today that its management team will be presenting at the Sidoti & Company Fall Small-Cap Virtual Investor Conference. Hudson’s main presentation is scheduled for Thursday, September 22, 2022 at 1:00 pm ET. [...]GlobeNewswire - US19 Sep 2022
Oportun to Participate in the Sidoti September Virtual Investor ConferenceSAN CARLOS, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech and digital banking platform, today announced that it will participate in the upcoming Sidoti September Virtual Investor Conference.GlobeNewswire - US19 Sep 2022
ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech ConferenceSAN CLEMENTE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer and Tom Stankovich, Chief Financial Officer, will be participating in one-on-one meetings with institutional investors during the A. [...]GlobeNewswire - US14 Sep 2022
Wave Life Sciences to Present at Upcoming Investor ConferencesCAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investors conferences in May. [...]GlobeNewswire - US10 May 2022
The Greenrose Holding Company to Present at Upcoming May Investor ConferencesAMITYVILLE, N.Y., May 10, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) (“Greenrose” or the “Company”), a multi-state grower and producer of cannabis brands and products, is scheduled to participate in the following virtual investor conferences in May 2022:GlobeNewswire - US10 May 2022
ReShape Lifesciences to Present at the Q2 Investor SummitManagement will also Present to Members of the Philadelphia Securities Association Management will also Present to Members of the Philadelphia Securities AssociationGlobeNewswire - US26 Apr 2022
Driven Brands to Present at the Morgan Stanley Virtual Global Consumer & Retail ConferenceCHARLOTTE, N.C., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Driven Brands Holdings Inc. (NASDAQ: DRVN) announces that Jonathan Fitzpatrick, president and chief executive officer, and Tiffany Mason, executive vice president and chief financial officer, will present at the Morgan Stanley Virtual Global Consumer & Retail Conference on Tuesday, November 30, 2021. [...]GlobeNewswire - US23 Nov 2021
Interpublic Group to Present at the Morgan Stanley European Technology, Media and Telecom ConferenceNew York, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) senior management will present at the Morgan Stanley European Technology, Media & Telecom Conference on Wednesday, November 17th 2021, at 1:15 pm Eastern time, as scheduled.GlobeNewswire - US12 Nov 2021
Dentsply Sirona to Present at Upcoming Virtual Investor ConferencesCHARLOTTE, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) - announced today that the Company will present at three upcoming investor conferences.GlobeNewswire - US09 Nov 2021
Athira Pharma to Present at Upcoming Investor Conferences-Stifel 2021 Virtual Healthcare Conference-- Jefferies 2021 London Healthcare Conference-GlobeNewswire - US08 Nov 2021
Surrozen to Present at The Stifel 2021 Virtual Healthcare ConferenceSOUTH SAN FRANCISCO, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (Nasdaq: SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced that Craig Parker, Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference at 4:40 p. [...]GlobeNewswire - US05 Nov 2021
Upwork to Present at the 2021 RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual ConferenceSAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent, as measured by gross services volume (“GSV”), today announced that President and CEO, Hayden Brown, and Chief Financial Officer, Jeff McCombs, will participate in a fireside chat at the 2021 RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference on Wednesday, November 17, 2021, at 11:40 a. [...]GlobeNewswire - US04 Nov 2021
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Present at the 2021 International Head and Neck Cancer ConferenceFLORHAM PARK, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that the company’s Chief Medical Officer, Dr. [...]GlobeNewswire - US27 Oct 2021
Wayside Technology Group Sets Third Quarter 2021 Conference Call for November 4, 2021 at 8:30 a.m. ETEATONTOWN, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Wayside Technology Group, Inc. (NASDAQ: WSTG) (“Wayside” or the “Company”), a global value-added IT channel company providing innovative sales and distribution solutions for emerging technology vendors, will host a conference call on Thursday, November 4, 2021 at 8:30 a. [...]GlobeNewswire - US21 Oct 2021
Weyland Tech to Present at Wall Street Reporter’s Virtual Investor Conference on Wednesday, July 22, 2020NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) -- Weyland Tech, Inc. (OTCQX: WEYL), a leading global provider of eCommerce, mCommerce, and fintech business enablement solutions, has been invited to present at Wall Street Reporter’s Next Super Stock Live! virtual investor conference tomorrow, Wednesday, July 22, 2020 at 12:30 p. [...]GlobeNewswire - US21 Jul 2020
Ryder System Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. – Ryder System Investors Reminded Of July 20, 2020 Lead Plaintiff DeadlinePHILADELPHIA, July 20, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Ryder System, Inc. (“Ryder System” or the “Company”) (NYSE: R) to determine whether Ryder System may have violated federal securities laws.GlobeNewswire - US20 Jul 2020
Elanco Animal Health Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. – Elanco Animal Health Investors Reminded of July 20, 2020 Lead Plaintiff DeadlinePHILADELPHIA, July 20, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) to determine whether Elanco may have violated federal securities laws.GlobeNewswire - US20 Jul 2020
Enabled by smarttopics.mimyr.com
Refreshed on 16 Apr 2024
© 2018-Present EZINTEG LLC - Terms of use -